Company intelligence / Profile preview

Cardigant Medical

Campbell, California, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Cardigant Medical is a medical technology company focused on developing innovative transcatheter solutions for structural heart disease. As a portfolio company of the Shifamed incubator, it is specifically dedicated to addressing tricuspid regurgitation through a novel transcatheter tricuspid valve replacement (TTVR) system. The company's technology aims to provide a minimally invasive alternative for patients who are at high risk for traditional open-heart surgery. Cardigant's approach leverages advanced engineering to improve valve performance and ease of delivery within the complex anatomy of the right heart.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Shifamed

Beyond the preview

Go deeper on Cardigant Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardigant Medical.

Explore the full profile